The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current discoveries include the functional role of collagen in bone development and disease, molecular determinants of lung cancer histology, a role for long noncoding RNAs in breast cancer metabolism, a new regulatory factor in hypoxia-induced...
ABSTRACTS 691, 371, 794
Combination therapies including venetoclax and another therapy have displayed promising results against subtypes...
ABSTRACTS 93, 739, 2
Three clinical studies led by researchers at The University of Texas MD Anderson Cancer Center demonstrated enhanced...
ATLANTA ― The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into basic, translational and clinical cancer research from MD Anderson experts. This special edition features presentations at the 2021 American Society of Hematology (ASH) Annual Meeting on innovative targeted therapies, new combination approaches, and novel cellular therapies to improve treatments for patients with leukemia, lymphoma...
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational...
Results from a Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center showed that treatment with belzutifan...
New research from The University of Texas MD Anderson Cancer Center found that treatment with antihistamines, a commonly used allergy medication...
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational...
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into basic, translational and clinical cancer research...
The Oden Institute for Computational Engineering and Sciences (Oden Institute), The University of Texas MD Anderson Cancer Center ...